Sector Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 2026-08-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.210 USD | -0.31% |
|
+7.00% | +16.73% |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| Aug. 11 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 368M | - | ||||
| 48.84B | |||||
| 45.44B | - | - | - | - | - |
| 41.22B | |||||
| 39.71B | |||||
| 32.6B |
Select your edition
All financial news and data tailored to specific country editions
